|
1
|
Versari D, Daghini E, Virdis A, Ghiadoni L
and Taddei S: Endothelial dysfunction as a target for prevention of
cardiovascular disease. Diabetes Care. 32(Suppl 2): S314–S321.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cersosimo E and DeFronzo RA: Insulin
resistance and endothelial dysfunction: The road map to
cardiovascular diseases. Diabetes Metab Res Rev. 22:423–436. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davignon J and Ganz P: Role of endothelial
dysfunction in atherosclerosis. Circulation. 109(23 Suppl 1):
IIII27–III32. 2004. View Article : Google Scholar
|
|
4
|
Reaven GM: Banting lecture 1988. Role of
insulin resistance in human disease. Diabetes. 37:1595–1607. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wheatcroft SB, Williams IL, Shah AM and
Kearney MT: Pathophysiological implications of insulin resistance
on vascular endothelial function. Diabetic Med. 20:255–268. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heitzer T, Schlinzig T, Krohn K, Meinertz
T and Münzel T: Endothelial dysfunction, oxidative stress and risk
of cardiovascular events in patients with coronary artery disease.
Circulation. 104:2673–2678. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ginsberg HN: Insulin resistance and
cardiovascular disease. J Clin Invest. 106:453–458. 2000.
View Article : Google Scholar
|
|
8
|
Kubota T, Kubota N, Kumagai H, Yamaguchi
S, Kozono H, Takahashi T, Inoue M, Itoh S, Takamoto I, Sasako T, et
al: Impaired insulin signaling in endothelial cells reduces
insulin-induced glucose uptake by skeletal muscle. Cell Metab.
13:294–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rask-Madsen C, Li Q, Freund B, Feather D,
Abramov R, Wu IH, Chen K, Yamamoto-Hiraoka J, Goldenbogen J,
Sotiropoulos KB, et al: Loss of insulin signaling in vascular
endothelial cells accelerates atherosclerosis in apolipoprotein E
null mice. Cell Metab. 11:379–389. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim F, Pham M, Maloney E, Rizzo NO, Morton
GJ, Wisse BE, Kirk EA, Chait A and Schwartz MW: Vascular
inflammation, insulin resistance and reduced nitric oxide
production precede the onset of peripheral insulin resistance.
Arterioscler Thromb Vasc Biol. 28:1982–1988. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okamoto H, Obici S, Accili D and Rossetti
L: Restoration of liver insulin signaling in Insr knockout mice
fails to normalize hepatic insulin action. J Clin Invest.
115:1314–1322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garcia Soriano F, Virág L, Jagtap P, Szabó
E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL,
et al: Diabetic endothelial dysfunction: The role of
poly(ADP-ribose) polymerase activation. Nat Med. 7:108–113. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rask-Madsen C and King GL: Mechanisms of
disease: Endothelial dysfunction in insulin resistance and
diabetes. Nat Clin Pract Endocrinol Metab. 3:46–56. 2007.
View Article : Google Scholar
|
|
14
|
Arcaro G, Cretti A, Balzano S, Lechi A,
Muggeo M, Bonora E and Bonadonna RC: Insulin causes endothelial
dysfunction in humans sites and mechanisms. Circulation.
105:576–582. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Burén J, Liu HX, Lauritz J and Eriksson
JW: High glucose and insulin in combination cause insulin receptor
substrate-1 and-2 depletion and protein kinase B desensitisation in
primary cultured rat adipocytes: Possible implications for insulin
resistance in type 2 diabetes. Eur J Endocrinol. 148:157–167. 2003.
View Article : Google Scholar
|
|
16
|
Gelosa P, Cimino M, Pignieri A, Tremoli E,
Guerrini U and Sironi L: The role of HMG-CoA reductase inhibition
in endothelial dysfunction and inflammation. Vasc Health Risk
Manag. 3:567–577. 2007.PubMed/NCBI
|
|
17
|
Durazzo AE, Machado FS, Ikeoka DT, De
Bernoche C, Monachini MC, Puech-Leão P and Caramelli B: Reduction
in cardiovascular events after vascular surgery with atorvastatin:
A randomized trial. J Vasc Surg. 39:967–975; discussion 975–976.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chello M, Goffredo C, Patti G, Candura D,
Melfi R, Mastrobuoni S, Di Sciascio G and Covino E: Effects of
atorvastatin on arterial endothelial function in coronary bypass
surgery. Eur J Cardiothorac Surg. 28:805–810. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cantley LC: The phosphoinositide 3-kinase
pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dilaveris P, Giannopoulos G, Riga M,
Synetos A and Stefanadis C: Beneficial effects of statins on
endothelial dysfunction and vascular stiffness. Curr Vasc
Pharmacol. 5:227–237. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mahmoud MF, El-Nagar M and El-Bassossy HM:
Anti-inflammatory effect of atorvastatin on vascular reactivity and
insulin resistance in fructose fed rats. Arch Pharm Res.
35:155–162. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calisto KL, Carvalho B, Ropelle ER,
Mittestainer FC, Camacho AC, Guadagnini D, Carvalheira JB and Saad
MJ: Atorvastatin improves survival in septic rats: Effect on tissue
inflammatory pathway and on insulin signaling. PLoS One.
5:e142322010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Shi Y, Wei Y, Ma X, Li Y and Li R:
Altered expression profiles of microRNAs upon arsenic exposure of
human umbilical vein endothelial cells. Environ Toxicol Pharmacol.
34:381–387. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmidt RJ and Baylis C: Total nitric
oxide production is low in patients with chronic renal disease.
Kidney Int. 58:1261–1266. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Lebovitz HE: Insulin resistance-a common
link between type 2 diabetes and cardiovascular disease. Diabetes
Obes Metab. 8:237–249. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tousoulis D, Antoniades C, Katsi V,
Bosinakou E, Kotsopoulou M, Tsioufis C and Stefanadis C: The impact
of early administration of low-dose atorvastatin treatment on
inflammatory process, in patients with unstable angina and low
cholesterol level. Int J Cardiol. 109:48–52. 2006. View Article : Google Scholar
|
|
28
|
Tousoulis D, Charakida M, Stefanadi E,
Siasos G, Latsios G and Stefanadis C: Statins in heart failure.
Beyond the lipid lowering effect. Int J Cardiol. 115:144–150. 2007.
View Article : Google Scholar
|
|
29
|
Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi
NN, Ozdelen E, Tuncman G, Görgün C, Glimcher LH and Hotamisligil
GS: Endoplasmic reticulum stress links obesity, insulin action, and
type 2 diabetes. Science. 306:457–461. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hribal ML, Perego L, Lovari S, Andreozzi
F, Menghini R, Perego C, Finzi G, Usellini L, Placidi C, Capella C,
et al: Chronic hyperglycemia impairs insulin secretion by affecting
insulin receptor expression, splicing and signaling in RIN beta
cell line and human islets of Langerhans. FASEB J. 17:1340–1342.
2003.PubMed/NCBI
|
|
31
|
Muniyappa R and Quon MJ: Insulin action
and insulin resistance in vascular endothelium. Curr Opin Clin Nutr
Metab Care. 10:523–530. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gonzalez-Gay MA, De Matias JM,
Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J
and Llorca J: Anti-tumor necrosis factor-alpha blockade improves
insulin resistance in patients with rheumatoid arthritis. Clin Exp
Rheumatol. 24:83–86. 2006.PubMed/NCBI
|
|
33
|
De Taeye BM, Novitskaya T, McGuinness OP,
Gleaves L, Medda M, Covington JW and Vaughan DE: Macrophage
TNF-alpha contributes to insulin resistance and hepatic steatosis
in diet-induced obesity. Am J Physiol Endocrinol Metab.
293:E713–E725. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
López-Sepúlveda R, Gómez-Guzmán M,
Zarzuelo MJ, Romero M, Sánchez M, Quintela AM, Galindo P, O'Valle
F, Tamargo J, Pérez-Vizcaíno F, et al: Red wine polyphenols prevent
endothelial dysfunction induced by endothelin-1 in rat aorta: Role
of NADPH oxidase. Clin Sci (Lond). 120:321–333. 2011. View Article : Google Scholar
|
|
35
|
Zhang H, Zhang J, Ungvari Z and Zhang C:
Resveratrol Improves endothelial function: Role of TNF{alpha} and
vascular oxidative stress. Arterioscler Thromb Vasc Biol.
29:1164–1171. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wong V, Stavar L, Szeto L, Uffelman K,
Wang CH, Fantus IG and Lewis GF: Atorvastatin induces insulin
sensitization in Zucker lean and fatty rats. Atherosclerosis.
184:348–355. 2006. View Article : Google Scholar
|
|
37
|
Lalli CA, Pauli JR, Prada PO, Cintra DE,
Ropelle ER, Velloso LA and Saad MJ: Statin modulates insulin
signaling and insulin resistance in liver and muscle of rats fed a
high-fat diet. Metabolism. 57:57–65. 2008. View Article : Google Scholar
|
|
38
|
Calisto KL, Carvalho Bde M, Ropelle ER,
Mittestainer FC, Camacho AC, Guadagnini D, Carvalheira JB and Saad
MJ: Atorvastatin improves survival in septic rats: Effect on tissue
inflammatory pathway and on insulin signaling. PloS One.
5:e142322010. View Article : Google Scholar : PubMed/NCBI
|
